ImageneBio annual operating expenses
2020
2021
2022
2023
2024
2025
ImageneBio Operating Expenses Growth & History (IMA)
ImageneBio's operating expenses was $49.3M for fiscal 2025.
View full ImageneBio company overviewImageneBio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $49.3M | $8.8M | +21.61% |
| 2024 | 2024-12-31 | $40.5M | −$44.1M | −52.11% |
| 2023 | 2023-12-31 | $84.6M | −$1.9M | −2.25% |
| 2022 | 2022-12-31 | $86.5M | $21.4M | +32.86% |
| 2021 | 2021-12-31 | $65.1M | $11.4M | +21.24% |
| 2020 | 2020-12-31 | $53.7M | — | — |
ImageneBio quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.8M | $4.4M | +60.15% |
| Q1 2026 | 2026-03-31 | $12.1M | $5.3M | +77.76% |
| Q4 2025 | 2025-12-31 | $8.5M | $7.6M | +829.40% |
| Q3 2025 | 2025-09-30 | $26.6M | $21.1M | +380.38% |
| Q2 2025 | 2025-06-30 | $7.4M | −$8.5M | −53.50% |
| Q1 2025 | 2025-03-31 | $6.8M | −$11.4M | −62.72% |
| Q4 2024 | 2024-12-31 | $915,000 | −$21.7M | −95.95% |
| Q3 2024 | 2024-09-30 | $5.5M | −$15.2M | −73.24% |
| Q2 2024 | 2024-06-30 | $15.8M | −$4.7M | −22.79% |
| Q1 2024 | 2024-03-31 | $18.2M | −$2.6M | −12.49% |
| Q4 2023 | 2023-12-31 | $22.6M | $2.0M | +9.73% |
| Q3 2023 | 2023-09-30 | $20.7M | −$3.6M | −14.79% |
| Q2 2023 | 2023-06-30 | $20.5M | −$839,000 | −3.93% |
| Q1 2023 | 2023-03-31 | $20.8M | $482,000 | +2.37% |
| Q4 2022 | 2022-12-31 | $20.6M | $3.1M | +18.02% |
| Q3 2022 | 2022-09-30 | $24.3M | $6.0M | +32.90% |
| Q2 2022 | 2022-06-30 | $21.3M | $5.1M | +31.39% |
| Q1 2022 | 2022-03-31 | $20.3M | $7.2M | +54.21% |
| Q4 2021 | 2021-12-31 | $17.4M | −$8.7M | −33.28% |
| Q3 2021 | 2021-09-30 | $18.3M | $9.2M | +101.59% |
| Q2 2021 | 2021-06-30 | $16.2M | $8.1M | +99.66% |
| Q1 2021 | 2021-03-31 | $13.2M | $2.8M | +26.83% |
| Q4 2020 | 2020-12-31 | $26.1M | — | — |
| Q3 2020 | 2020-09-30 | $9.1M | — | — |
| Q2 2020 | 2020-06-30 | $8.1M | — | — |
| Q1 2020 | 2020-03-31 | $10.4M | — | — |
ImageneBio operating expenses trends
Over the last five fiscal years, ImageneBio's operating expenses decreased from $53.7M to $49.3M, a change of −$4.5M. The latest reported quarter, Q2 2026, shows $11.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ImageneBio source filings ↗